Osteopontin expression predicts overall survival after liver transplantation for hepatocellular carcinoma in patients beyond the Milan criteria

Journal of Hepatology

Volumn 54, Issue 1, 2011, Pages 89-97

  Sieghart, Wolfgang ^a   Wang, Xiaowei ^a,b   Schmid, Katharina ^a   Pinter, Matthias ^a   König, Franz ^a   Bodingbauer, Martin ^a   Wrba, Fritz ^a   Rasoul Rockenschaub, Susanne ^a   Peck Radosavljevic, Markus ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b JILIN UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Liver transplantation; Osteopontin; Recurrence; Survival

Indexed keywords

OSTEOPONTIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE; TUMOR RECURRENCE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OSTEOPONTIN; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 78649632996     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.06.030     Document Type: Article

References (45)

1. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108
2. J. Bruix, and M. Sherman Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
3. Primary Liver Cancer in Japan. Clinicopathologic features and results of surgical treatment. Liver Cancer Study Group of Japan. Ann Surg 1990;211:277-287.
4. T. Nagao, S. Inoue, F. Yoshimi, M. Sodeyama, Y. Omori, and T. Mizuta Postoperative recurrence of hepatocellular carcinoma Ann Surg 211 1990 28 33
5. T. Genda, M. Sakamoto, T. Ichida, H. Asakura, M. Kojiro, and S. Narumiya Cell motility mediated by rho and Rho-associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinoma Hepatology 30 1999 1027 1036
6. K. Yuki, S. Hirohashi, M. Sakamoto, T. Kanai, and Y. Shimosato Growth and spread of hepatocellular carcinoma. A review of 240 consecutive autopsy cases Cancer 66 1990 2174 2179
7. I. Penn Hepatic transplantation for primary and metastatic cancers of the liver Surgery 110 1991 726 734 [discussion 734-725]
8. R. Pichlmayr, A. Weimann, and B. Ringe Indications for liver transplantation in hepatobiliary malignancy Hepatology 20 1994 33S 40S
9. V. Mazzaferro, E. Regalia, R. Doci, S. Andreola, A. Pulvirenti, and F. Bozzetti Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis [see comments] N Engl J Med 334 1996 693 699
10. K. Shetty, K. Timmins, C. Brensinger, E.E. Furth, S. Rattan, and W. Sun Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome Liver Transplant 10 2004 911 918
11. A.W. Hemming, M.S. Cattral, A.I. Reed, W.J. Van Der Werf, P.D. Greig, and R.J. Howard Liver transplantation for hepatocellular carcinoma Ann Surg 233 2001 652 659
12. G.B. Klintmalm Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome Ann Surg 228 1998 479 490
13. J.N. Vauthey, D. Klimstra, D. Franceschi, Y. Tao, J. Fortner, and L. Blumgart Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma Am J Surg 169 1995 28 34 discussion 34-25
14. A. Villanueva, P. Newell, D.Y. Chiang, S.L. Friedman, and J.M. Llovet Genomics and signaling pathways in hepatocellular carcinoma Semin Liver Dis 27 2007 55 76
15. H.W. Pan, Y.H. Ou, S.Y. Peng, S.H. Liu, P.L. Lai, and P.H. Lee Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma Cancer 98 2003 119 127
16. Q.H. Ye, L.X. Qin, M. Forgues, P. He, J.W. Kim, and A.C. Peng Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning Nat Med 9 2003 416 423
17. J. Kim, S.S. Ki, S.D. Lee, C.J. Han, Y.C. Kim, and S.H. Park Elevated plasma osteopontin levels in patients with hepatocellular carcinoma Am J Gastroenterol 101 2006 2051 2059
18. H. Zhang, Q.H. Ye, N. Ren, L. Zhao, Y.F. Wang, and X. Wu The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma J Cancer Res Clin Oncol 132 2006 709 717
19. J. Agnholt, J. Kelsen, L. Schack, C.L. Hvas, J.F. Dahlerup, and E.S. Sorensen Osteopontin, a protein with cytokine-like properties, is associated with inflammation in Crohn's disease Scand J Immunol 65 2007 453 460
20. D.T. Denhardt, C.M. Giachelli, and S.R. Rittling Role of osteopontin in cellular signaling and toxicant injury Annu Rev Pharmacol Toxicol 41 2001 723 749
21. K.A. Furger, R.K. Menon, A.B. Tuckl, V.H. Bramwelll, and A.F. Chambers The functional and clinical roles of osteopontin in cancer and metastasis Curr Mol Med 1 2001 621 632
22. M. Gotoh, M. Sakamoto, K. Kanetaka, M. Chuuma, and S. Hirohashi Overexpression of osteopontin in hepatocellular carcinoma Pathol Int 52 2002 19 24
23. D.R. Senger, B.B. Asch, B.D. Smith, C.A. Perruzzi, and H.F. Dvorak A secreted phosphoprotein marker for neoplastic transformation of both epithelial and fibroblastic cells Nature 302 1983 714 715
24. A.J. Oates, R. Barraclough, and P.S. Rudland The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model Oncogene 13 1996 97 104 (Pubitemid 26248549)
25. P.Y. Wai, and P.C. Kuo The role of osteopontin in tumor metastasis J Surg Res 121 2004 228 241
26. C.Y. Wu, M.S. Wu, E.P. Chiang, C.C. Wu, Y.J. Chen, and C.J. Chen Elevated plasma osteopontin associated with gastric cancer development, invasion and survival Gut 56 2007 782 789
27. F. Rohde, C. Rimkus, J. Friederichs, R. Rosenberg, C. Marthen, and D. Doll Expression of osteopontin, a target gene of de-regulated Wnt signaling, predicts survival in colon cancer Int J Cancer 121 2007 1717 1723
28. L.R. Rodrigues, J.A. Teixeira, F.L. Schmitt, M. Paulsson, and H. Lindmark-Mansson The role of osteopontin in tumor progression and metastasis in breast cancer Cancer Epidemiol Biomarkers Prev 16 2007 1087 1097
29. A. Ramankulov, M. Lein, G. Kristiansen, H.A. Meyer, S.A. Loening, and K. Jung Elevated plasma osteopontin as marker for distant metastases and poor survival in patients with renal cell carcinoma J Cancer Res Clin Oncol 133 2007 643 652
30. R. Cui, F. Takahashi, R. Ohashi, T. Gu, M. Yoshioka, and K. Nishio Abrogation of the interaction between osteopontin and alphavbeta3 integrin reduces tumor growth of human lung cancer cells in mice Lung Cancer 57 2007 302 310
31. G. Chakraborty, S. Jain, and G.C. Kundu Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms Cancer Res 68 2008 152 161
32. A. Bellahcene, V. Castronovo, K.U. Ogbureke, L.W. Fisher, and N.S. Fedarko Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer Nat Rev 8 2008 212 226
33. International Union Against Cancer (UICC). Liver. In: Sobin LH, Wittekind C, editors. TNM classification of malignant tumours, 6th ed. New York, NY: Wiley & Sons; 2002. p. 74-76.
34. H.A. Edmondson, and P.E. Steiner Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies Cancer 7 1954 462 503
35. A. Thelen, A. Scholz, W. Weichert, B. Wiedenmann, P. Neuhaus, and R. Geszner Tumor-Associated Angiogenesis and Lymphangiogenesis Correlate With Progression of Intrahepatic Cholangiocarcinoma Am J Gastroenterol 105 2010 1123 1132
36. L.F. Brown, A. Papadopoulos-Sergiou, B. Berse, E.J. Manseau, K. Tognazzi, and C.A. Perruzzi Osteopontin expression and distribution in human carcinomas Am J Pathol 145 1994 610 623
37. P.V. Korita, T. Wakai, Y. Shirai, Y. Matsuda, J. Sakata, and X. Cui Overexpression of osteopontin independently correlates with vascular invasion and poor prognosis in patients with hepatocellular carcinoma Human Pathol 39 2008 1777 1783
38. A.M. Gonzalez-Angulo, J.K. Litton, K.R. Broglio, F. Meric-Bernstam, R. Rakkhit, and F. Cardoso High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller J Clin Oncol 27 2009 5700 5706
39. F.Y. Yao, L. Ferrell, N.M. Bass, P. Bacchetti, N.L. Ascher, and J.P. Roberts Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria Liver Transplant 8 2002 765 774
40. V. Mazzaferro, J.M. Llovet, R. Miceli, S. Bhoori, M. Schiavo, and L. Mariani Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis Lancet Oncol 10 2009 35 43
41. N. Iizuka, Y. Hamamoto, and M. Oka Predicting individual outcomes in hepatocellular carcinoma Lancet 364 2004 1837 1839
42. D. Agrawal, T. Chen, R. Irby, J. Quackenbush, A.F. Chambers, and M. Szabo Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling J Natl Cancer Inst 94 2002 513 521
43. J. Zhao, L. Dong, B. Lu, G. Wu, D. Xu, and J. Chen Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis Gastroenterology 135 2008 956 968
44. B.-S. Sun, Q.-Z. Dong, Q.-H. Ye, H.-J. Sun, H.-L. Jia, and X.-Q. Zhu Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma Hepatology 48 2008 1834 1842
45. V. Takafuji, M. Forgues, E. Unsworth, P. Goldsmith, and X.W. Wang An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma Oncogene 26 2007 6361 6371